IDEXX Laboratories Forecasts FY24 EPS Of $10.84-$11.33 Versus Consensus Of $11.00, Reflecting Reported And Organic Growth Of 8%-13%
Portfolio Pulse from Benzinga Newsdesk
IDEXX Laboratories projects its FY24 EPS to be in the range of $10.84-$11.33, aligning with the consensus estimate of $11.00. This forecast indicates a reported and organic growth of 8%-13%.
February 05, 2024 | 11:38 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IDEXX Laboratories forecasts FY24 EPS of $10.84-$11.33, closely aligning with consensus estimates and indicating a growth of 8%-13%.
The forecasted EPS range by IDEXX Laboratories for FY24 closely matches the consensus estimate, suggesting a positive outlook on the company's financial health and growth prospects. This alignment with consensus estimates, coupled with the projected growth of 8%-13%, is likely to be viewed positively by investors, potentially leading to an increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100